Health Care: Drugs

Dr Reddy's Laboratories Ltd (RDY: NYSE)

$46.17 -0.43 | -0.92%
12/07/16 - 10:36 AM ET
Company Income Statement
Mar 2016 Mar 2015 Mar 2014 Mar 2013
Sales 2.33B 2.37B 2.21B 2.14B
Cost of Sales 553.06M 874.43M 823.18M 921.54M
Gross Operating Profit 1.78B 1.50B 1.39B 1.22B
Selling, General, and Administrative Expenses 647.35M 680.93M 648.06M 629.92M
Research & Development 0.00 279.01M 207.24M 141.05M
Operating Income before D & A (EBITDA) 1.13B 535.17M 530.07M 444.47M
Depreciation & Amortization 154.37M 129.52M 118.74M 101.99M
Interest Income 0.00 16.97M 18.13M 16.54M
Other Income - Net -532.15M 42.05M 33.50M 56.19M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 442.97M 467.79M 465.87M 417.12M
Interest Expense 12.44M 17.46M 21.29M 18.71M
Pre-Tax Income 430.54M 450.33M 444.59M 398.40M
Income Taxes 113.12M 95.68M 85.12M 90.06M
Minority Interest 0.00 0.00 -50.13K -18.38K
Net Income From Continuing Operations 317.42M 354.64M 359.47M 308.34M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 317.42M 354.64M 359.47M 308.34M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 317.42M 354.64M 359.52M 308.36M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
317.42M 354.64M 359.47M 308.34M
Preferred Dividends
Net Income Available To Common 317.42M 354.64M 359.47M 308.34M
Basic EPS from Continuing Ops. 1.88 2.08 2.11 1.82
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.88 2.08 2.11 1.82
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.88 2.08 2.11 1.82
Basic Normalized Net Income/Share 1.88 2.08 2.11 1.82
EPS fr Continuing Ops. 1.88 2.07 2.11 1.81
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.88 2.07 2.11 1.81
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.88 2.07 2.11 1.81
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.88 2.07 2.11 1.81
Dividends Paid per Share 0.31 0.29 0.26 0.23

Portfolios with RDY

Latest RDY Headlines from TheStreet

More Financial News for RDY

Press Releases for RDY

See All Press Releases

Partner Headlines for RDY

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter